Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Obesity In a survey done in 2022, approximately 38.6 percent of Filipino adults aged 20 to 59 were overweight or obese
Pros: Strong behavioral tools grounded in psychology Easy-to-use app with daily structure Combines prescribed weight loss drugs with habit change Good option for emotional or pattern-based eaters Cons: The medication side is newer and less established than dedicated medical providers Coaching leans on automation rather than frequent human contact Pricing climbs once you add Med services to the base subscription 6
Ready to Start Your Weight Loss Journey in Philadelphia
The GLP-1 receptor agonists liraglutide and semaglutide are already well-established for their glucoregulatory and weight-loss effects in patients with type 2 diabetes (T2DM) and overweight/obesity [13,14,15]
Medication, exercise, and nutrition are often combined in medically supervised weight loss programs that include GLP-1 drugs such as tirzepatide
,aspect=ignore)
